Vertical: CNMBase Year: 2025
Market Size (2025)
$678.87M
Projected (2032)
$1.32B
CAGR (2022–2032)
10.0%
Key Players
9+
Market Overview
The Global Viral Biopesticides Market was valued at USD 678.87 million in 2025 and is projected to reach USD 1,321.89 million by 2032, registering a CAGR of 9.97% during the forecast period 2026–2032. The market has expanded steadily from USD 508.19 million in 2022, and the absolute increase between 2025 and 2032 is estimated at USD 643.02 million, indicating that the market will nearly double over the forecast horizon.
Viral biopesticides are insecticidal products whose active ingredient is an insect-pathogenic virus, predominantly members of the family Baculoviridae: nucleopolyhedroviruses (NPVs, genus Alphabaculovirus) and granuloviruses (GVs, genus Betabaculovirus). These viruses are highly host-specific, infect the larval stages of target insects after ingestion, and pose no known risk to humans, vertebrates, pollinators or most natural enemies. Their commercial value lies in combining effective control of key caterpillar pests with low residue and low environmental risk, which makes them compatible with integrated pest management (IPM), residue-sensitive export supply chains, organic production and insecticide resistance management programmes.
Demand is being shaped by four structural forces: tightening regulation of synthetic insecticides, particularly in the European Union; widespread resistance of lepidopteran pests such as Helicoverpa armigera, Spodoptera frugiperda and Cydia pomonella to chemical modes of action; retailer and consumer pressure for residue-free fruit and vegetables; and the rapid scaling of bioinputs in Latin American row crops, where baculoviruses are now applied across millions of hectares of soybean, cotton and maize. The market is also seeing consolidation, with large agrochemical groups acquiring specialist virus producers.
Key Findings
By Formulation: Liquid (SC) was the largest segment in 2025 at USD 475.21 million (70.0% share) and is also the fastest-growing segment, with a CAGR of 10.66% over 2026–2032.
By Crop Type: Fruits & Vegetables held the largest share at 50.0% (USD 339.44 million) in 2025 and is the fastest-growing crop segment, with a CAGR of 10.62%.
By Target Pest: Lepidoptera dominated with 90.0% of the market (USD 610.99 million) in 2025, while the Others segment is the fastest-growing, at a CAGR of 12.03%.
By Region: North America was the leading region in 2025 with USD 224.03 million (33.0% share). Middle East & Africa is the fastest-growing region, with a CAGR of 12.27%, closely followed by Asia Pacific at 11.98%.
By Country: The U.S. was the leading country market in 2025 at USD 179.22 million, accounting for 80.0% of the North American market. India is the fastest-growing country, with a CAGR of 14.12% over 2026–2032.
Segmentation Summary
By formulation, Liquid (SC) products accounted for USD 475.21 million in 2025 and are expected to reach USD 966.96 million by 2032, while Dry formulations are projected to grow from USD 203.66 million to USD 354.93 million at a CAGR of 8.23%. Suspension concentrates dominate because most commercial baculoviruses are produced in vivo and formulated as aqueous suspensions of occlusion bodies that mix easily in standard spray equipment; dry formulations (wettable powders and water-dispersible granules) retain an important role where cold-chain logistics are limited.
By crop type, Fruits & Vegetables accounted for USD 339.44 million in 2025, reflecting the long-established use of codling moth granulovirus in pome fruit and of NPVs in greenhouse and field vegetables. Cotton & Field Crops represented USD 237.61 million (35.0% share) and is projected to reach USD 453.41 million by 2032 at a CAGR of 9.66%, driven largely by soybean, cotton and maize in Latin America and Asia. The Others segment, which includes forestry, turf, ornamentals and other crops, was valued at USD 101.83 million.
By target pest, Lepidoptera (moths and butterflies, whose larvae are the primary hosts of commercial baculoviruses) is projected to grow from USD 610.99 million in 2025 to USD 1,171.20 million in 2032. The Others segment, covering viral products for non-lepidopteran pests such as sawflies and emerging virus-based solutions for other insect orders, is expected to grow from USD 67.89 million to USD 150.70 million.
Regionally, North America (USD 224.03 million) and Europe (USD 162.93 million) are the most mature markets, while Latin America (USD 142.56 million) and Asia Pacific (USD 122.20 million) are the principal engines of growth. Brazil, valued at USD 88.39 million in 2025, and China, at USD 43.99 million, are the largest country markets outside North America and Europe.
Competitive Landscape Summary
The market is moderately consolidated at the global level and fragmented at the regional level. A small group of specialists with proprietary virus strains and in vivo production capacity, led by Andermatt Group AG and AgBiTech (acquired by BASF SE in March 2026), account for a large part of global supply, supported by Certis Biologicals (Mitsui & Co., Ltd.), UPL Ltd. and Koppert. In Brazil, domestic producers such as Life Biological Control, Simbiose Biociências and Promip compete in Spodoptera frugiperda control, often with technology licensed from Embrapa. Competition centres on strain efficacy, production cost per hectare, shelf life, registration breadth and agronomic support.
Challenges and Opportunities
The principal challenges are the narrow host range of individual viruses, slower speed of kill compared with synthetic insecticides, sensitivity to ultraviolet radiation, the cost and complexity of in vivo production in live insect larvae, and lengthy registration processes in some jurisdictions. Documented field resistance of codling moth to certain CpGV isolates in Europe has also underlined the need for strain diversification. Opportunities lie in multi-virus products that control pest complexes, improved UV-protective and shelf-stable formulations, expanding low-risk active substance pathways in the European Union, the growth of bioinputs in Brazil under its dedicated bioinputs legislation, and rising adoption in India and other Asia Pacific markets where Helicoverpa and Spodoptera pressure is severe.
Future Outlook
The market is expected to grow from USD 747.29 million in 2026 to USD 1,321.89 million by 2032. Growth will be supported by integration of viral products into chemical-biological programmes in broad-acre crops, continued substitution of withdrawn synthetic insecticides in specialty crops, and investment in production capacity and strain libraries by both specialists and multinational crop protection companies. Latin America and Asia Pacific are expected to add USD 158.17 million and USD 148.13 million respectively between 2025 and 2032, increasing their weight in the global market, while North America and Europe will remain the largest value pools for high-value fruit and vegetable applications.
The Viral Biopesticides Market market is projected to grow at a CAGR of 10.0% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Viral biopesticides are crop protection products in which the active ingredient is a naturally occurring, insect-specific virus that causes a lethal infection in the target pest. The commercially dominant group is the Baculoviridae, comprising nucleopolyhedroviruses (NPVs) and granuloviruses (GVs). Baculovirus particles are embedded in a protein matrix, known as an occlusion body (polyhedra for NPVs and granules for GVs), which protects the virions in the environment. When a susceptible larva ingests treated foliage or fruit, the occlusion bodies dissolve in the alkaline midgut, releasing virions that infect midgut cells and then spread systemically. Infected larvae stop feeding, typically die within three to ten days depending on the virus, temperature and larval stage, and liquefy, releasing large numbers of new occlusion bodies that can cause secondary infection in the pest population.
Commercial products are typically produced in vivo by rearing host larvae on artificial diet, infecting them, harvesting and purifying the virus, and formulating it with stabilisers, UV protectants and adjuvants. Products are standardised by the number of occlusion bodies per litre or kilogram. Examples include codling moth granulovirus (CpGV) products for apples and pears, Helicoverpa armigera NPV (HearNPV) and Helicoverpa zea NPV (HzSNPV) for cotton, soybean, maize and vegetables, Spodoptera frugiperda multiple NPV (SfMNPV) for fall armyworm, Chrysodeixis includens NPV for soybean looper, Spodoptera exigua and Spodoptera littoralis NPVs for vegetables, and Phthorimaea operculella GV (PhopGV) for potato tuber moth and tomato leaf miner.
Included in the scope: registered and commercially sold crop protection products whose primary active ingredient is an insect-pathogenic virus, in liquid suspension concentrate (SC) and dry (wettable powder, water-dispersible granule and similar) formulations, used on fruits and vegetables, cotton and field crops, and other crops, against lepidopteran and other insect pests. Market value is measured at the manufacturer level.
Excluded from the scope: bacterial biopesticides (such as Bacillus thuringiensis), fungal biopesticides (such as Beauveria bassiana and Metarhizium spp.), entomopathogenic nematodes, botanical insecticides, semiochemicals and pheromones, macrobial biological control agents, RNA interference products, viruses used for vector or public-health control, viruses used in biomedical or recombinant protein expression applications, and on-farm or non-registered virus preparations.
Scope of the Study
The study analyses the Global Viral Biopesticides Market in terms of value (USD Million) across three product and application segmentations and five regions with their constituent countries, as structured in the market data. The historic period covers 2022, 2023 and 2024, 2025 is the base year, and the forecast period is 2026–2032. Growth rates are expressed as compound annual growth rates (CAGR) for 2026–2032.
Research Objectives
To define, describe and quantify the global viral biopesticides market by formulation, crop type, target pest and region over 2022–2032.
To estimate the market size in the base year 2025 and forecast it to 2032, with growth rates for each segment, region and country.
To analyse the drivers, restraints, opportunities, trends and challenges specific to baculovirus and other virus-based insecticides, including resistance to synthetic insecticides and restrictions on chemical active substances.
To examine the value chain, from host insect rearing and virus production through formulation, registration and distribution to growers.
To assess the regulatory frameworks governing microbial and low-risk pest control products in the major regions and their influence on product approvals and market entry.
To evaluate the competitive intensity of the market using Porter’s Five Forces and PESTEL frameworks.
To identify the leading companies and benchmark their product portfolios, regional presence, strategic alliances and industry experience.
To track key developments since 2022, including acquisitions, product registrations, partnerships and capacity expansions.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The research followed a structured, multi-stage process combining secondary research, primary research and analytical modelling. The process began with defining the market and its segmentation, followed by an extensive review of published information to build an understanding of products, applications, producers and regulations. Initial market estimates were then developed using top-down and bottom-up approaches and refined through consultations with industry participants. Finally, the estimates were triangulated, validated for internal consistency across segments, regions and countries, and used as the basis for the forecast.
Stage 1 – Market definition and scoping: definition of viral biopesticides, inclusion and exclusion criteria, and segmentation framework.
Stage 2 – Secondary research: collection of data on product registrations, company activities, crop areas, pest pressure and regulations.
Stage 3 – Primary research: discussions with supply-side and demand-side participants to validate assumptions and gather qualitative insights.
Stage 4 – Market estimation and forecasting: base-year sizing, segment splits and forecast modelling.
Stage 5 – Validation and triangulation: cross-checking of estimates from multiple approaches and final review.
Secondary Research
Secondary research formed the foundation of the study and covered the following source categories relevant to the viral biopesticides industry:
Industry associations: biological crop protection associations such as the International Biocontrol Manufacturers Association (IBMA), the Biological Products Industry Alliance (BPIA), CropLife International and its regional bodies, and national bioinputs associations in Brazil and India.
Government and regulatory bodies: pesticide registration databases and decisions of the U.S. Environmental Protection Agency, the European Commission and the European Food Safety Authority, Health Canada’s Pest Management Regulatory Agency, Brazil’s Ministry of Agriculture and Livestock (MAPA), India’s Central Insecticides Board and Registration Committee, and China’s Institute for the Control of Agrochemicals.
Public research institutions: publications and technology releases from Embrapa, ICAR institutes, USDA Agricultural Research Service and university entomology departments working on baculovirus production and field efficacy.
Company filings and communications: annual reports, investor presentations, press releases, product labels and technical bulletins of virus producers, agrochemical companies and distributors.
Trade journals and scientific literature: agricultural trade press, peer-reviewed journals on insect pathology and biological control, and conference proceedings.
Statistical and paid databases: crop area and production statistics from FAO and national agencies, trade data, and subscription databases on agricultural inputs and company financials.
Primary Research
Primary research was conducted to validate secondary findings, fill information gaps and obtain qualitative insight into market dynamics. Interviews were conducted through telephone, video calls and structured questionnaires with participants across the value chain.
Supply-side respondents: senior executives, product managers, R&D and production managers at viral biopesticide manufacturers, agrochemical companies with biological portfolios, contract formulators, and regulatory affairs consultants.
Demand-side respondents: distributors and agricultural retailers, crop consultants and agronomists, procurement managers at large farming groups and fruit and vegetable growers’ cooperatives, and researchers at public agricultural institutes.
Objectives: to validate market size and segment splits, understand pricing and cost per hectare, assess adoption barriers and drivers by crop and region, evaluate competitive positioning, and gather views on regulatory changes and the product pipeline.
Market Size Estimation
Top-down approach: the overall biopesticides and bioinsecticides market was used as a starting point, and the share attributable to virus-based products was derived using registration data, company revenues and expert inputs. This total was then allocated across formulations, crops, target pests, regions and countries using adoption and penetration ratios.
Bottom-up approach: the market was built up from estimates of treated area by crop and country, application rates and number of applications per season, and average product prices, cross-checked against the revenues of leading manufacturers in the viral product category.
Data triangulation: results from the top-down and bottom-up approaches were compared, and differences were reconciled through additional secondary research and primary interviews. The final estimates were checked for consistency so that segment, regional and country values add up to the respective totals for every year.
Forecasting Methodology
The forecast was developed using a combination of trend analysis, driver-based modelling and expert judgement. Historic growth from 2022 to 2025 was analysed and projected forward, adjusted for the expected impact of the following factors:
Area under key host crops and the incidence of target lepidopteran pests, including invasive species such as fall armyworm.
Regulatory restrictions and withdrawals of synthetic insecticide active substances, and approval timelines for new viral active substances.
Development of insecticide resistance and adoption of resistance management programmes.
Growth of organic and residue-sensitive production and retailer residue requirements.
Production capacity additions, cost reductions and formulation improvements by manufacturers.
Macroeconomic conditions, farm income and agricultural commodity prices.
Base Year, Forecast Period and Currency
Base year: 2025
Historic period: 2022–2024
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency: USD Million, at constant exchange rates
Assumptions and Limitations
Market values are estimated at the manufacturer level and exclude distribution margins and taxes.
Exchange rates are assumed constant over the forecast period; currency movements are not modelled.
The regulatory environment is assumed to evolve along currently announced trajectories, with no abrupt bans on viral biopesticides in major markets.
No major disruption to agricultural production, such as a global pandemic or extreme trade restrictions, is assumed during the forecast period.
Private companies do not publish revenues for viral products; estimates for these companies rely on indirect indicators and expert interviews.
Product-level data in some emerging markets is limited, and estimates for aggregated geographies are subject to a wider margin of uncertainty.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global viral biopesticides market is moderately consolidated at the global level and fragmented at the regional level. A small number of specialist companies with proprietary virus isolates, in vivo production capacity and multi-country registrations supply a large part of the market, while numerous regional and domestic producers serve specific pests and crops, particularly in Brazil, China and India. Competition is based on the efficacy and spectrum of virus strains, production cost and scale, formulation quality and shelf life, breadth of registrations, and the strength of agronomic support and distribution partnerships.
The competitive structure is changing as multinational agrochemical companies enter the segment through acquisitions and partnerships, most notably BASF’s acquisition of AgBiTech in 2026, and as specialist leaders consolidate distributors and smaller producers to extend their geographic reach. In Brazil, public technology transfer from Embrapa has enabled several domestic companies to launch fall armyworm products, intensifying competition in the largest growth market.
Key Player Positioning
Leaders: Andermatt Group AG and AgBiTech (BASF SE) are the leading companies in the market. Andermatt, founded in 1988 in Switzerland, has one of the broadest viral portfolios, covering codling moth, summer fruit tortrix, Helicoverpa, Spodoptera, Tuta absoluta and other pests, with manufacturing in Switzerland, Germany and Canada and operations in more than 60 countries. AgBiTech, founded in Australia in 2000, is a leading supplier of baculovirus products for row crops, with manufacturing in the United States and a leading position in Brazil’s virus-based bioinsecticide market; its acquisition by BASF gives it access to a global commercial network.
Challengers: Certis Biologicals (Mitsui & Co., Ltd.), UPL Ltd. and Koppert hold established positions in specific products and regions. Certis Biologicals markets granulovirus and NPV products in the United States and benefits from Mitsui’s European platform, Certis Belchim. UPL, through its NPP business, offers the codling moth granulovirus product Carpovirusine and has partnered with AgBiTech for distribution in the United States. Koppert, a global biological control leader, added the fall armyworm virus product Buick to its Brazilian portfolio in 2022.
Niche and regional players: Life Biological Control, Simbiose Biociências and Promip in Brazil, and River Bioscience in South Africa, focus on specific pests and markets. The Brazilian companies compete in Spodoptera frugiperda, Chrysodeixis and Helicoverpa control, partly using Embrapa-derived technology, while River Bioscience specialises in viruses for citrus and deciduous fruit pests and has partnered with Oro Agri (Rovensa) to develop CrpeNPV in Europe.
Competitor Dashboard
The dashboard below rates the profiled companies on four qualitative parameters relevant to competitiveness in viral biopesticides.
Threat of New Entrants – Medium
Proprietary virus isolates, insect rearing know-how and registration dossiers create meaningful barriers to entry.
Registration costs and timelines, particularly in the European Union and the United States, deter small entrants.
Public technology transfer, such as Embrapa-developed SfMNPV technology in Brazil, has lowered barriers in some markets, enabling new domestic producers.
Bargaining Power of Suppliers – Low
Most inputs, including diet ingredients and formulants, are commodities available from multiple suppliers.
The most critical inputs, virus strains and insect colonies, are generally controlled by manufacturers themselves.
Specialised equipment and contract formulation services are available from several providers.
Bargaining Power of Buyers – Medium
Large distributors, cooperatives and farming groups purchase in volume and negotiate on price.
Growers can choose among chemical, Bt-based and other biological alternatives.
Buyer power is moderated by the limited number of effective viral products for specific pests and by the value of resistance management and residue benefits.
Threat of Substitutes – High
Synthetic insecticides offer broad-spectrum control and faster knockdown, often at lower cost per hectare.
Bacillus thuringiensis products, fungal biopesticides, pheromone-based mating disruption and Bt crops compete for the same pest control budget.
Emerging technologies such as RNA interference and peptide-based bioinsecticides may provide further alternatives.
Intensity of Competitive Rivalry – Medium
A limited number of global specialists compete in many pest–crop niches, which moderates rivalry.
Competition is intensifying in Brazil’s Spodoptera and Helicoverpa segments, where several domestic producers compete with established players.
Entry of multinational companies through acquisitions is raising competitive pressure on independent producers.
Threat of New Entrants: Medium; Strain IP, production know-how and registration barriers, partly offset by public technology transfer.
Bargaining Power of Suppliers: Low; Commodity inputs; strategic inputs held in-house.
Bargaining Power of Buyers: Medium; Concentrated distribution and available alternatives, balanced by product differentiation.
Threat of Substitutes: High; Chemical insecticides, Bt products, other biologicals and Bt crops.
Intensity of Competitive Rivalry: Medium; Few global specialists; rising competition in Latin America and from multinationals.
Market estimates by geography (2032)
InsightNorth America leads with $386.26M by 2032, while Asia Pacific is projected to grow fastest at a 12.0% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $173.53M | $262.51M | $386.26M | 8.3% | 29% |
| Europe | $123.91M | $194.91M | $303.37M | 9.4% | 23% |
| Asia Pacific | $86.94M | $153.79M | $270.33M | 12.0% | 20% |
| Latin America | $103.48M | $176.81M | $300.73M | 11.3% | 23% |
| Middle East & Africa | $20.33M | $34.38M | $61.20M | 11.7% | 5% |
| Total | $508.19M | $822.39M | $1.32B | 10.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.32B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Liquid (SC) | $966.96M | 10.7% | 73% |
| Dry | $354.93M | 8.4% | 27% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Viral Biopesticides Market covering market dynamics, competitive landscape, and strategic outlook.
The Viral Biopesticides Market market is projected to reach $1.32B by 2032, growing at 10.0% CAGR. The Liquid (SC) segment holds the largest share.
The Global Viral Biopesticides Market is influenced by a combination of regulatory, agronomic, technological and commercial factors. The shift away from broad-spectrum synthetic insecticides, the spread of resistant and invasive lepidopteran pests, and growing demand for residue-free produce are creating sustained demand for highly selective biological insecticides. At the same time, intrinsic product characteristics such as host specificity, speed of action and production economics continue to limit the pace of adoption. This chapter analyses these forces through a growth factor assessment and a discussion of drivers, restraints, opportunities, trends and challenges.
Market Growth Factor Analysis
The table below summarises five macro factors and five micro factors that influence the market, the direction of their impact, and the strength of that impact over three forecast sub-periods. The impact scores, on a scale of 1 (minimal impact) to 10 (very strong impact), are analyst assessments based on the secondary and primary research conducted for this study.
Regulatory Restrictions on Synthetic Insecticides
Regulators in several major markets are narrowing the range of synthetic insecticides available to growers. In the European Union, Regulation (EC) No 1107/2009 applies hazard-based approval criteria, and a number of widely used insecticides, including chlorpyrifos and chlorpyrifos-methyl, were not renewed in 2020, while the outdoor use of several neonicotinoids had already been restricted. Each withdrawal removes a tool for lepidopteran control in fruit, vegetables and arable crops and creates an opening for selective alternatives. Viral biopesticides benefit directly because many baculoviruses qualify as low-risk active substances, are exempt from maximum residue limits, and impose no pre-harvest interval constraints. Similar pressure is visible in other regions through stricter residue limits, re-evaluation programmes and national strategies to reduce chemical pesticide use, such as China’s action plan for zero growth in pesticide use and Japan’s MIDORI strategy for sustainable food systems. As the number of available chemical modes of action declines, growers and advisers increasingly build programmes in which viruses are used to control early larval instars and reduce reliance on the remaining synthetic products, supporting steady volume growth for viral products across fruit and vegetable crops.
Insecticide Resistance and Invasive Lepidopteran Pests
Lepidopteran pests such as Helicoverpa armigera, Spodoptera frugiperda, Spodoptera litura, Chrysodeixis includens and Plutella xylostella have developed resistance to multiple classes of synthetic insecticides, and field-evolved resistance to certain Bt traits has been documented in parts of the Americas and Asia. The arrival of fall armyworm in West Africa in 2016 and its subsequent spread across Africa and into India in 2018 and the wider Asia Pacific region has added a highly damaging, polyphagous pest to maize and other crops in markets with limited control options. Because baculoviruses act through a completely different mechanism from chemical insecticides and Bt proteins, they are valuable rotation partners in insecticide resistance management programmes. Their host specificity also preserves parasitoids and predators that provide additional natural control. Agronomists in Brazil, Argentina, the United States and Australia increasingly recommend viral products as a standard component of caterpillar management in soybean, cotton and maize, either as stand-alone applications at early infestation or in combination with reduced rates of chemical partners.
Demand for Residue-Free Produce and Organic Production
Large food retailers in Europe and North America frequently set private residue limits that are stricter than legal maximum residue limits, and export-oriented growers in Latin America, Africa and Asia must comply with the requirements of their destination markets. Viral biopesticides leave no residues of toxicological concern, and most are exempt from tolerance or MRL requirements, which allows them to be used close to harvest without compromising compliance. This is particularly valuable in apples, pears, stone fruit, grapes, tomatoes, peppers, leafy vegetables and brassicas, which are subject to intensive residue monitoring. Organic production is a further source of demand: the European Union’s Farm to Fork strategy set an objective of 25% of agricultural land under organic farming by 2030, and organic growers depend heavily on biological insecticides because synthetic products are not permitted. Codling moth granulovirus has long been a cornerstone of organic pome fruit production, and NPV products for Helicoverpa, Spodoptera and other caterpillars are widely used in organic vegetable systems. Continued growth in organic area and in residue-sensitive exports supports demand in the fruits and vegetables segment.
Scaling of Bioinputs in Latin American Row Crops
The most significant change in the market over recent seasons has been the rapid adoption of baculoviruses in broad-acre crops in South America. Brazil has a supportive policy environment for bioinputs, including the National Bioinputs Program established by Decree No. 10.375 of 2020 and Law No. 15.070 of December 2024, which created a dedicated legal framework for the production and use of bioinputs. Producers report large treated areas: AgBiTech stated in 2025 that around 6 million hectares of cotton, soybean and maize are treated with its products in South America, and Life Biological Control reports use of its baculovirus products on more than 20 million hectares in Brazil since launch. Growers are adopting viral products for Helicoverpa armigera, Spodoptera frugiperda, Chrysodeixis includens and Rachiplusia nu because they provide effective control, fit into existing spray programmes and support resistance management. Distributors and cooperatives are actively promoting these products, and the availability of locally produced, room-temperature-stable wettable powders is widening access. This dynamic underpins the strong growth expected in Latin America and in the cotton and field crops segment.
Multi-Virus Products for Pest Complexes
Combining two or more viruses in a single product addresses the narrow host range limitation and simplifies grower decision-making. Producers are developing and launching mixtures that target the caterpillar complexes found in soybean and cotton, such as Helicoverpa, Spodoptera and Chrysodeixis species. In Brazil, Life Biological Control has announced dual and triple baculovirus products for market availability from 2027. Such products can raise the value per hectare, broaden the addressable market and strengthen the case for viruses as a core component of caterpillar management rather than a niche tool.
Expansion in Asia Pacific and Africa
Asia Pacific and Africa combine large areas of cotton, maize, pulses and vegetables with severe pressure from Helicoverpa, Spodoptera and fall armyworm, while penetration of registered viral products remains relatively low. India has a long history of NPV use and a registration pathway for biopesticides under the Insecticides Act, 1968, and governments across the region are promoting biological control. Improved, standardised product quality and partnerships with established distributors offer significant growth potential for producers able to adapt formulations and pricing to smallholder farming systems.
New Active Substances and Strain Diversification
Regulatory pathways for low-risk substances are creating opportunities for new viral active ingredients. In February 2025, Phthorimaea operculella granulovirus (PhopGV), used against potato tuber moth and tomato leaf miner, was approved as a low-risk active substance in the European Union. New isolates and alternative viruses, such as Cryptophlebia peltastica NPV, which has shown activity against codling moth strains with reduced susceptibility to granulovirus, offer tools for resistance management and allow producers to extend portfolios into new pests and crops.
Narrow Host Range and Slower Speed of Kill
The host specificity that makes viral biopesticides environmentally attractive also limits their commercial reach. Most baculoviruses infect a single pest species or a small group of closely related species, so growers facing a complex of caterpillars or other pests often need additional products, which raises costs and complexity. In addition, infected larvae continue to feed for several days before dying, and efficacy is highest against early instars, which requires accurate monitoring and timely application. Growers accustomed to the rapid knockdown of synthetic insecticides may perceive viral products as less reliable, particularly under heavy infestation, and this perception remains a barrier in markets with limited technical advisory support.
Production Complexity, Cost and Product Stability
Commercial baculoviruses cannot yet be produced economically in cell culture at scale and are manufactured in living host larvae. This requires the continuous rearing of insect colonies on artificial diet, strict biosecurity to prevent colony contamination, and labour-intensive harvesting and purification. Production cost per hectare is therefore higher than for many generic chemical insecticides, and capacity expansion requires significant lead time. Once applied, occlusion bodies are inactivated by ultraviolet radiation, which shortens field persistence, and some liquid formulations require refrigerated storage, which complicates distribution in tropical markets.
Regulatory Complexity and Registration Timelines
Although many jurisdictions have adapted their rules for microbial products, registration remains costly and slow in some markets. In the European Union, approval of a new active substance followed by zonal product authorisation can take many years, and each virus isolate may require separate assessment. Small and medium-sized producers, which account for much of the innovation in this field, often lack the resources to register products in multiple countries, limiting the availability of products outside their home markets.
Challenge: Product Quality and Consistency
In some markets, particularly where small-scale producers supply locally, variability in virus concentration, contamination and storage conditions has led to inconsistent field performance. Inconsistent quality undermines grower confidence in the category as a whole, making quality control standards, regulatory enforcement and producer reputation important factors for market development.
Challenge: Grower Awareness and Technical Support Requirements
Successful use of viral products depends on correct timing, pest identification and application technique. Delivering this knowledge requires sustained investment in field demonstrations, agronomic advice and training of distributors and farmers, which raises the cost of market development, especially in fragmented smallholder markets.
Trend: Consolidation and Entry of Multinational Agrochemical Companies
Large agrochemical companies are acquiring or partnering with viral biopesticide specialists to add biological insecticides to their portfolios. BASF completed its acquisition of AgBiTech in March 2026, and specialist leaders are themselves consolidating, as illustrated by Andermatt Group’s acquisition of the Canadian granulovirus producer BioTEPP in 2024. This trend is bringing greater commercial reach, investment and integration of viruses into combined chemical-biological programmes.
Trend: Formulation Innovation and Integrated Programmes
Manufacturers are improving UV protection, shelf life and room-temperature stability, and are developing products designed to be tank-mixed with chemical partners. Integrated programmes in which viruses are applied at early infestation and combined with reduced rates of synthetic insecticides are increasingly recommended by agronomists, improving efficacy while lowering chemical load.
The value chain of viral biopesticides differs from that of synthetic insecticides because the active ingredient is produced biologically in living host insects. Value is concentrated in proprietary virus strains, insect rearing and production know-how, and registration assets.
Raw Materials and Inputs
Key inputs include master seed stocks of characterised virus isolates, healthy and pathogen-free host insect colonies, artificial diet ingredients (such as soybean flour, wheat germ, yeast, agar, vitamins and preservatives), formulation components (UV protectants, stickers, dispersants, thickeners, carriers and preservatives), and packaging materials. Most of these inputs are widely available commodities; the strategic inputs are the virus strains and insect colonies, which manufacturers develop and maintain in-house.
Manufacturing
Manufacturing involves mass rearing of host larvae, inoculation with the virus, incubation, harvest of infected larvae, homogenisation, filtration and purification of occlusion bodies, followed by formulation into suspension concentrates or dry powders and granules. Quality control covers occlusion body counts, bioassays to confirm biological activity, and microbial contaminant testing. Production is concentrated in specialised facilities in Switzerland, Canada, the United States, Brazil, South Africa, China and India.
Registration, Distribution and Channels
Products must be registered with national regulators before sale. Distribution takes place through agrochemical distributors and retailers, agricultural cooperatives, partnerships with multinational crop protection companies, and direct sales to large farming groups, supported by technical advisory teams. Liquid products may require a cold chain from factory to farm, while dry formulations are typically stored at ambient temperature.
End Users
End users include pome and stone fruit growers, greenhouse and field vegetable producers, cotton, soybean and maize farmers, organic producers, and forestry and amenity managers. Large row-crop farms and export-oriented fruit and vegetable producers are the most significant buyers by value.
North America
United States: pesticides are regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Microbial pesticides are reviewed by the EPA’s Biopesticides and Pollution Prevention Division, with data requirements set out in 40 CFR Part 158, Subpart V. Many baculoviruses are exempt from the requirement of a tolerance on food commodities.
Canada: products are regulated under the Pest Control Products Act by Health Canada’s Pest Management Regulatory Agency (PMRA), which applies specific data requirements for microbial pest control agents.
Mexico: pesticide registration is administered by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), with involvement of SENASICA in plant health matters.
Europe
European Union: active substances are approved under Regulation (EC) No 1107/2009, and products are authorised by Member States. Commission Regulation (EU) 2017/1432 set criteria for low-risk active substances, and Regulations (EU) 2022/1438 to 2022/1441 updated approval criteria, data requirements and evaluation principles specifically for micro-organisms.
Residues and sustainable use: Regulation (EC) No 396/2005 governs maximum residue levels, with many micro-organisms listed in Annex IV, where no MRL is required. Directive 2009/128/EC on the sustainable use of pesticides requires Member States to promote integrated pest management and non-chemical methods.
United Kingdom: Great Britain operates its own regime based on retained Regulation (EC) No 1107/2009, administered by the Health and Safety Executive.
Asia Pacific
India: biopesticides, including NPV products, are registered under the Insecticides Act, 1968 by the Central Insecticides Board and Registration Committee (CIB&RC).
China: pesticides are registered under the Regulations on Pesticide Administration, revised in 2017, with registration administered by the Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA).
Japan: products are registered under the Agricultural Chemicals Control Act, and the Ministry of Agriculture, Forestry and Fisheries’ MIDORI strategy aims to reduce risk-weighted chemical pesticide use by 50% by 2050.
Latin America
Brazil: pesticide registration is governed by Law No. 14.785 of December 2023, with the Ministry of Agriculture and Livestock (MAPA) as the coordinating registrant authority. Decree No. 10.375 of 2020 established the National Bioinputs Program, and Law No. 15.070 of December 2024 created a dedicated framework for bioinputs, including on-farm production.
Argentina: plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa
South Africa: agricultural remedies, including biological products, are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Saudi Arabia: pesticide registration is administered by the Ministry of Environment, Water and Agriculture.
United Arab Emirates: pesticide registration is administered by the Ministry of Climate Change and Environment.
May 2022: AgBiTech; UPL; Partnership; UPL and AgBiTech announced a partnership to deliver AgBiTech’s biological insect control solutions to growers in the western United States.
May 2022: Mitsui & Co., Ltd.; Merger; Mitsui announced the creation of Certis Belchim B.V. by merging Certis Europe with Belchim Crop Protection, combining biological and conventional portfolios in Europe.
September 2022: Koppert; Product Portfolio Expansion; The Brazilian registration of the fall armyworm virus bioinsecticide Buick was transferred from AgBiTech to Koppert.
January 2023: River Bioscience; Oro Agri (Rovensa); Partnership; Distribution and development agreement for the CrpeNPV baculovirus against codling moth and oriental fruit moth, starting in Europe.
February 2023: AgBiTech; UPL; Distribution Expansion; AgBiTech expanded the distribution of its biosolutions in the United States through UPL.
March 2024: Certis Biologicals; Acquisition; Certis Biologicals acquired multiple assets from AgBiome, including the Howler and Theia biofungicides, broadening its biological portfolio.
July 2024: Andermatt Group AG; Acquisition; Andermatt acquired Canadian company BioTEPP Inc., developer of the granulovirus product Virosoft CP4 for codling moth and oriental fruit moth.
October 2024: Andermatt Group AG; Acquisition; Andermatt acquired an 80% stake in Agricheck Srl, its distribution partner of more than 20 years in Argentina.
November 2024: AgBiTech; Market Expansion; AgBiTech reported that its baculovirus products cover around 5 million hectares of soybean, maize and cotton in Brazil.
February 2025: Andermatt Group AG; Regulatory Approval; Phthorimaea operculella granulovirus (PhopGV), the active ingredient of Tutavir, was approved as a low-risk active substance in the European Union.
February 2025: Andermatt Group AG; Expansion; Andermatt launched Andermatt Italia S.r.l. as its newest subsidiary.
April 2025: Life Biological Control; Capacity Expansion; The company announced plans for a new biofactory in Brazil to triple production capacity.
January 2026: BASF SE; AgBiTech; Acquisition; BASF signed an agreement with Paine Schwartz Partners and other shareholders to acquire AgBiTech.
March 2026: BASF SE; Acquisition; BASF completed the acquisition of AgBiTech on 31 March 2026, adding baculovirus-based insecticides and manufacturing in the U.S., Australia and Brazil to its Agricultural Solutions business.
August 2026: Life Biological Control; Product Launch; The company presented Destroyer Duo and Destroyer Triple multi-baculovirus products, scheduled for market availability from 2027.
Political
National strategies to reduce chemical pesticide use, such as the EU Farm to Fork strategy and Japan’s MIDORI strategy, favour biological solutions.
Government programmes promoting bioinputs, such as Brazil’s National Bioinputs Program, support local production and adoption.
Trade policies and export-market requirements influence the pest control choices of export-oriented growers.
Economic
Farm income and commodity prices affect growers’ willingness to pay for premium biological products.
Production cost per hectare of in vivo produced viruses remains higher than for many generic insecticides.
Investment and acquisition activity by large agrochemical companies is increasing capital available to the sector.
Social
Consumer demand for residue-free and organic food supports adoption in fruit and vegetable crops.
Concern about farmworker exposure to chemical insecticides favours products with minimal handling risk.
Limited awareness among smallholder farmers slows adoption in some developing markets.
Technological
Advances in strain selection, genotype mixing and co-occlusion technology enable products for pest complexes.
Improved UV protectants and room-temperature-stable formulations extend persistence and shelf life.
Research into cell-culture production could, in the long term, lower production costs and increase scalability.
Environmental
High host specificity preserves pollinators, natural enemies and aquatic organisms.
Climate change is expanding the range and generation numbers of lepidopteran pests, increasing control needs.
Viruses are sensitive to UV radiation and high temperatures, which affects field persistence.
Legal
Dedicated microbial and low-risk regulatory pathways, such as the EU micro-organism regulations of 2022, ease approval of viral active substances.
Lengthy and isolate-specific registration requirements in some jurisdictions raise market entry costs.
Intellectual property protection for virus isolates and production processes shapes competitive positioning.
Profiles of 108 companies operating in the Viral Biopesticides Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
4 interactive charts drawn from the Viral Biopesticides Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Viral Biopesticides Market By Target Pest
Global Viral Biopesticides Market By Crop Type
Global Viral Biopesticides Market By Formulation
Global Viral Biopesticides Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
